Switch to: Citations

Add references

You must login to add references.
  1. Bringing Known Drugs to Pediatric Research: Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.Akshay Sharma & Liza-Marie Johnson - 2020 - American Journal of Bioethics 20 (4):106-108.
    Volume 20, Issue 4, May 2020, Page 106-108.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Balancing Risk and Reward: Greater Research Oversight Is Appropriate for Novel Therapies for Children With Life-Limiting Illness.Yoram Unguru - 2020 - American Journal of Bioethics 20 (4):104-105.
    Volume 20, Issue 4, May 2020, Page 104-105.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations.Benjamin S. Wilfond, Devan M. Duenas & Liza-Marie Johnson - 2020 - American Journal of Bioethics 20 (4):102-103.
    Volume 20, Issue 4, May 2020, Page 102-103.
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.Kathryn M. Porter, Anne Stevens & Benjamin S. Wilfond - 2020 - American Journal of Bioethics 20 (4):116-118.
    Volume 20, Issue 4, May 2020, Page 116-118.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.Robert M. Nelson - 2020 - American Journal of Bioethics 20 (4):114-116.
    Volume 20, Issue 4, May 2020, Page 114-116.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Autism Advocacy Before and After DSM-5.Ryan H. Nelson - 2020 - American Journal of Bioethics 20 (4):48-50.
    Volume 20, Issue 4, May 2020, Page 48-50.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.Jeff Matsler & Jamila M. Young - 2020 - American Journal of Bioethics 20 (4):118-120.
    Volume 20, Issue 4, May 2020, Page 118-120.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Balancing Scientific Progress With Pediatric Protections: No Direct Benefit Now, But Potential Novel Therapy in the Future.Susannah W. Lee & Jessica C. Ginsberg - 2020 - American Journal of Bioethics 20 (4):108-110.
    Volume 20, Issue 4, May 2020, Page 108-110.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?Liza-Marie Johnson, Devan M. Duenas & Benjamin S. Wilfond - 2020 - American Journal of Bioethics 20 (4):111-113.
    Volume 20, Issue 4, May 2020, Page 111-113.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
    • Home | Bibliographies | About PhilArchive | Contact us | Code of conduct

    CDP Phiosophy Documentation Center
    PhilPapers logo by Andrea Andrews and Meghan Driscoll.
    This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications).

    Use of this site is subject to terms & conditions.
    All rights reserved by The PhilPapers Foundation

    Server: philpapers-web-6b65f85844-pflvk uwo